Federal and state regulators cracked down on storefronts that partner with mail order operations illegally importing drugs into the U.S. at the same time the Illinois governor is considering an Rx import plan for state employees.
PBMs Significantly Marked Up Specialty Generic Drugs
The Federal Trade Commission released its second interim staff report on industry-leading pharmacy benefit managers and their practices specifically regarding specialty drugs.
Podcast: Is The Pharmacy World Prepared For DSCSA?
Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.
DOJ Lawsuit Alleges CVS Helped Fuel Opioid Epidemic Through Unlawful Opioid Prescriptions
The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.
Keep Up With Policy Changes Affecting Independent Pharmacy
This special Over the Counter episode, brought to you by Total Pharmacy® and Omega Pharmacy Group, dives into how to navigate the business of independent pharmacy and get ahead of key policy changes.
Finish The Fight: Patients Can Push PBM Reform Legislation Over the Finish Line | NCPA 2024
PBM reform legislation has progressed further in Congress than ever before.
Texas Sues Multiple PBMs, Drug Manufacturers Over Inflated Insulin Prices
On October 3,2024, Texas Attorney General Ken Paxton issued the lawsuit, which involves Eli Lilly, Express Scripts, CVS Pharmacy, and other pharmaceutical entities.